Genmab AS Stock Performance
as on April 24, 2026 at 5:09 am IST
Day's Low
Day's High
$26.82$27.57
0.74%
Downside
2.04%
Upside
52 Week's Low
52 Week's High
$18.89$35.4330.11%
Downside
31.13%
Upside
Genmab AS share price movements today
- Previous Close
- $27.69
- Open
- $27.48
- Volume
- 681.8K
- Day's Low - High
- $26.82 - $27.57
- 52 Week Low - High
- $18.89 - $35.43
Genmab AS Historical Returns
- 1 Month Return
- + 7.83 %
- 3 Month Return
- -18.27 %
- 1 Year Return
- + 37.56 %
- 3 Year Return
- -32.45 %
- 5 Year Return
- -24.78 %
Genmab AS Stock Fundamentals & Key Indicators
Check Genmab AS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$16.6B
EPS (TTM)
1.1024
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.94%
PE Ratio (TTM)
17.57
Industry PE ratio
-9.801875
PEG Ratio
1.7544
EBITDA
1.3B
Revenue (TTM)
3.7B
Profit Margin
25.89%
Return On Equity TTM
17.54%
Genmab AS Stock Valuation
Track how Genmab AS P/E has moved over time to understand its valuation trends.
Genmab AS in the last 5 years
Lowest (10.37x)
June 30, 2025
Industry (-9.80x)
April 23, 2026
Today (17.57x)
April 23, 2026
Highest (64.13x)
September 30, 2021
Today’s Price to Earnings Ratio: 17.57x
Genmab AS vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genmab AS with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $16.6B | -24.78% | 17.57 | 25.89% | |
| BUY | $41.2B | 127.17% | 131.81 | 8.45% | |
| BUY | $111.1B | 100.86% | 28.5 | 32.94% | |
| NA | $34.7B | NA | 126.48 | 5.37% | |
| BUY | $79.0B | 52.79% | 18.02 | 31.41% |
Stock Returns calculator for Genmab AS Stock including INR - Dollar returns
The Genmab AS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Genmab AS investment value today
Current value as on today
₹1,47,965
Returns
₹47,965
(+47.96%)
Returns from Genmab AS Stock
₹34,228 (+34.23%)
Dollar Impact
₹13,737 (+13.74%)
Analyst Recommendation on Genmab AS Stock
Based on 31 analysts
61.29%
Buy
29.03%
Hold
9.68%
Sell
Based on 31 analysts, 61.29% of analysts recommend a 'BUY' rating for Genmab AS. Average target price of $37.14
Genmab AS Share Price Target
Get share price movements and forecasts by analysts on Genmab AS.
What analysts predicted
27.25%UPSIDE
Target Price
$37.14
Current Price
$27.02
Analyzed by
31 Analysts
Target
$37.14
Genmab AS target price $37.14, a slight upside of 27.25% compared to current price of $27.02. According to 31 analysts rating.
Genmab AS Stock’s Investor Sentiment and Interest
Search interest for Genmab AS Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Genmab AS Quarterly Profit & Loss
All numbers in Millions USD
Genmab AS Annual Profit & Loss
All numbers in Millions USD
Genmab AS Quarterly Cash Flow
All numbers in Millions USD
Genmab AS Annual Cash Flow
All numbers in Millions USD
Genmab AS News & Key Events
Today's Timeline - 22 April
Wed, 05:58 PM
-Goldman Sachs upgrades Genmab to buy, citing key drivers including lymphoma drug Epkinly.
Insights on Genmab AS
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, GMAB has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.02B → 1.05B (in $), with an average increase of 3.1% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 48.4% return, outperforming this stock by 80.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 2.12B → 30.90M (in $), with an average decrease of 86.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, GMAB stock has moved down by -2.2%
About Genmab AS
| Organisation | Genmab AS |
| Headquarters | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
| Industry | Biotechnology |
| CEO | Dr. Jan G.J. van de Winkel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Genmab AS
Name | Title |
|---|---|
Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
Mr. Gregory David Emil Mueller | Executive VP, General Counsel & Chief Legal Officer |
Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
Mr. Christopher Cozic | Executive VP & Chief People Officer |
Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
Mr. Takahiro Hamatani | Senior Director of Finance Japan & Non-Independent Director |
FAQs
What is Genmab AS share price today?
Genmab AS share price today is $27.02 as on . Genmab AS share today touched a day high of $27.57 and a low of $26.82.
What is the 52 week high and 52 week low for Genmab AS share?
Genmab AS share touched a 52 week high of $35.43 on and a 52 week low of $18.89 on . Genmab AS stock price today i.e. is trending at $27.02,which is 23.74% down from its 52 week high and 43.08% up from its 52 week low.
What is Genmab AS's market capitalisation today?
Genmab AS market capitalisation is $0.02T as on .
How to invest in Genmab AS Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab AS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab AS Shares that will get you 0.0555 shares as per Genmab AS share price of $27.02 per share as on April 23, 2026 at 11:39 pm IST.
What is the minimum amount required to buy Genmab AS Stock (GMAB) from India?
Indian investors can start investing in Genmab AS (GMAB) shares with as little as ₹94.085 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in Genmab AS stock (as per the Rupee-Dollar exchange rate as on ).
Based on Genmab AS share’s latest price of $27.02 as on April 23, 2026 at 11:39 pm IST, you will get 0.3701 shares of Genmab AS. Learn more about
fractional shares .
What are the returns that Genmab AS has given to Indian investors in the last 5 years?
Genmab AS stock has given -24.78% share price returns and 24.28% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?